Ustekinumab Biosimilars
Bestof

Ustekinumab Biosimilars

2311 × 1725 px November 14, 2025 Peter Bestof
2311×1725 Download

Ustekinumab Biosimilars is a high-quality image in the Bestof collection, available at 2311 × 1725 pixels resolution — ideal for both digital and print use.

Discover the mechanism of Ustekinumab. Learn how this biologic therapy targets IL-12 and IL-23 pathways to effectively treat psoriasis and Crohn's disease.

Image Details

TitleUstekinumab Biosimilars
Dimensions2311 × 1725 px
CategoryBestof
PublishedNovember 14, 2025
AuthorZeus
Downloads662
Views1,723

Read full article: Mechanism Of Ustekinumab

// More Images

Bestof The current state of the art for biological therapies and new small molecules in inflammatory ...

The current state of the art for biological therapies and new small molecules in inflammatory ...

1673 × 1117

Bestof Frontiers | Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related ...

Frontiers | Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related ...

1960 × 1487

Bestof Frontiers | Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

Frontiers | Interaction between gut microbiota and immune checkpoint inhibitor-related colitis

3508 × 2473

Bestof Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease | New England Journal of ...

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease | New England Journal of ...

2640 × 1708

Bestof JCM | Free Full-Text | The Role of IL-23 Inhibitors in Crohn’s Disease

JCM | Free Full-Text | The Role of IL-23 Inhibitors in Crohn’s Disease

4232 × 3565

Bestof Frontiers | Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

Frontiers | Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

2559 × 1567

Bestof Ustekinumab Biosimilars

Ustekinumab Biosimilars

2311 × 1725

Bestof Ustekinumab in Dermatology: Approved Indications and Off-label Uses

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

5543 × 2850

Bestof Frontiers | Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management

Frontiers | Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management

2303 × 1617

Bestof Ustekinumab in Dermatology: Approved Indications and Off-label Uses

Ustekinumab in Dermatology: Approved Indications and Off-label Uses

5543 × 4569

Bestof Frontiers | Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis

Frontiers | Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis

2008 × 1466

Bestof Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and ...

Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and ...

2795 × 2977

Bestof Ustekinumab in Pediatric Dermatology: An Updated Review

Ustekinumab in Pediatric Dermatology: An Updated Review

3465 × 3904

Bestof Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal ...

Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal ...

3338 × 1917

Bestof Immunopathogenesis Of Inflammatory Bowel Disease And Mechanisms Of Biological Therapies at Kate ...

Immunopathogenesis Of Inflammatory Bowel Disease And Mechanisms Of Biological Therapies at Kate ...

1711 × 1025